BNET Industries
Last Fiscal Year Sales:$13.4B
- Public
- US
Dow Jones Description
Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions, more than 100 projects in the pipeline and a long term plan for growth.
Chairman & Chief Executive OfficerArthur D. Levinson
Number of Employees 11,186
Contact Information
1 DNA Way
South San Francisco, California 94080-4990
(650) 225-1000
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Biogen Gains Edge in Drug Talks
-
Biogen says panel backs Genentech partnership
-
Biogen Idec, Inc. Massachusetts BIIB Announces Conclusion of Arbitration with Genentech, Inc. DNA
-
Arbitrator sides with Biogen in Rituxan dispute
-
Genentech licenses Bayhill drug for $25M cash, equity
-
Emerging Drug Developer: Bayhill Therapeutics
-
Roche Downplays Avastin Failure, Defends Genentech Deal Value
-
Tom Marsico Is Pound-the-Table Bullish
-
Drug firms eye deals to maintain growth
-
UC president recommends Desmond-Hellmann for UCSF chancellor
-
HIW, OSIP, SNY, WLT, FLEX and GMCR Expected To Be Higher After Earnings Releases on...
-
Genentech, Inc. (South San Francisco, CA)
-
UPDATE 1-Seattle Genetics Q1 loss wider-than-expected
-
Analyst Available to Comment on Avastin's Failure in Clinical Trial for Early-Stage...
News & Analysis
Filter by
genentech inc. - All News and Analysis
Survey Says: Biotech Investors Cry Over Genentech (And More)
Do you cry yourself to sleep at night because you miss Genentech so much? Fifty-eight percent of investors do, according to a Deutsche Bank survey that also provides a peek at H209 biotech events. by Trista Morrison
Life Science Looks to Big Pharma for Funding as Caution Still Reigns
The Burrill Report submits: By MARIE DAGHLIAN Last week's flurry of public-share offerings must have been a blip on the radar screen, as most life sciences companies look to private investors for much needed cash. And while the number of PIPEs and venture-capital financings continues at a fairly good...
With Avastin Effectiveness Questioned, Roche's Acquisition of Genentech Looks Hasty
The news for Roche on Avastin gets worse: Forbes' Matt Herper just published a lengthy piece which suggests, in layman's terms, that the $4.8 billion cancer drug kinda doesn't work very well. by Jim Edwards
Genentech's 'Good' Subsidy Hardly Helps Economic Development
Oregon Business Magazine quoted me in its article about two subsidies, one that clearly failed and one that, they say, worked. If you think these things ever work, here are the facts cited in the article regarding the "good" subsidy. Genentech DNA received over $32 million of incentives, in exchange...
Roche Q1: How Genentech Might Hurt Roche's Sales and Management Productivity
One counter-intutive question here is whether Roche's acquisition of Genentech will hurt Roche more than it hurts Genentech. by Jim Edwards
Dorfman: SEC Launched Insider Trading Probe on Pfizer-Wyeth, Merck-Schering and Roche-Genentech
The Huffington Post's Dan Dorfman reports that the SEC and FINRA another finance regulatory body have launched insider trading probes to figure out whether stock was improperly traded ahead of the wave of recent mergers in pharmaceuticals. Among the deals under scrutiny are Pfizer's acquisition of Wyeth,...
Genentech Seals Roche's Dominance of Oncology Market
EP Vantage submits: If there was such a thing as a global anti-trust commission they might have something to say about Roche’s (RHHBY.PK) acquisition of Genentech DNA with respect to the Swiss pharma giant’s projected domination of the oncology market; the pharmaceutical industry’s fastest growing and, in three years, biggest...
Immunogen: Moving on Up
David Rau submits: As evidenced by the volume of shares traded, [[IMGN]] still has not caught the fancy of investors or traders of substance. IMGN has moved up smartly from month ago lows of 4 dollars and is now trading in the $7 range. The volume remains around...
Roche Has Upper Hand in Battle for Genentech R&D Talent
Everyone thinks that the Roche-Genentech merger will destroy Genentech's "culture," either because the stuffy suits from Roche will crimp the grass-skirt-and-coconut-bra vibe at Genentech or because Genentech scientists will look at all the money they just made on their stock and leave. If that happens, all their knowledge -- and...
Roche-Genentech Takeover Will Cost 1,500 Jobs in N.J.; Roche Name to Go
The Roche takeover of Genentech will cost 1,500 jobs in New Jersey as sales and marketing positions are axed there. R&D staff look more secure, according to the Star-Ledger. The company will also change its name to Genentech. The move makes a mockery of a press conference...
Those who viewed this also viewed...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Susan Desmond-Hellmann MD | President, Product Development |
| David A. Ebersman | Executive Vice President and Chief Financial Officer |
| Hal Barron MD | Chief Medical Officer & Senior Vice President, Development |
| Stephen G. Juelsgaard | Executive Vice President, Secretary and Chief Compliance Officer |
| Ian T. Clark | Executive Vice President, Commercial |
| Patrick Y Yang PhD | Executive Vice President, Product Operations |
| Richard H Scheller PhD | Executive Vice President, Research |
| Marc Tessier-Lavigne | Senior Vice President, Res Drug Discovery |
| Robert Garnick | Senior Vice President, Regulatory, Quality & Compliance |
| Andrew C. Chan | Vice President, Immunology Res |
| Ann L. Lee | Vice President, Process Development |
| Anthony P. Hurley | Vice President, Fill, Finish Manufacturing |
| Ashraf Hanna | Vice President, Alliance Management & Pipeline Strategy Support |
| Charles Calderaro | Vice President, Corp Engineering |
| Charles Johnson | Vice President, Clinical Biotherapeutics |
| Claudia Estrin | Vice President, Decision Support & Commercial Innovation |
| Corsee D. Sanders | Vice President, Biometrics & Business Operations, Medical Affairs |
| David Broad | Vice President & General Manager, Oceanside Product Operations |
| David Schenkein | Vice President, Clinical Hematology & Oncology |
| Denise Smith-Hams | Vice President, HR |
| Francis Jackson | Vice President, Vacaville Prod Operations |
| Gary Harbour | Vice President, Commercial Quality, South San Francisco |
| Genesio Murano | Vice President, Regulatory Affairs |
| Gregory Baird | Vice President, Corp Communications |
| Gwendolyn Fyfe | Vice President, Clinical Hematology & Oncology |
| James P. Miller | Vice President |
| Jennifer E. Cook | Vice President, Marketing Development |
| John M Whiting | Vice President Finance, Treasury and Procurement |
| John Orwin | Vice President |
| John Pinion | Vice President, External Quality |
| Joseph Barta | Vice President, Compliance |
| Joseph S. McCracken | Vice President, Business Development |
| Karen McCormick | Vice President |
| Kenneth Hillan | Vice President, Development Sciences |
| Kent Lieginger | Vice President |
| Kevin McRaith | Vice President |
| Leonard Kanavy | Vice President, Commercial Operations |
| Markus Gemuend | Vice President, Manufacturing Collaborations |
| Martin Babler | Vice President |
| Michael D. Varney | Vice President, Small Molecule Drug Discovery |
| Michael P. Miller | Vice President, Sales & Marketing, HER Family |
| Pamela M. Klein | Vice President, Clinical Oncology |
| Peter Carberry | Vice President, Clinical Operations |
| Philippa Norman | Vice President, Global Supply Chain |
| Quinton C. Oswald | Vice President, Sales & Marketing |
| Richard B Brewer | Vice President, Marketing |
| Ronald C. Branning | Vice President, Quality, Global |
| Roy C. Hardiman | Vice President |
| Scott Carmer | Vice President, Sales & Marketing, Rituxan Immunology |
| Sean A. Johnston | Vice President |
| Timothy L. Moore | Vice President, Manufacturing, South San Francisco |
| Todd Pierce | Vice President, Corp IT |
| Todd Rich | Vice President, Clinical & Commercial Regulatory Affairs |
| Varun Nanda | Vice President |
| Vince Anicetti | Vice President, Prod Portfolio Management |
| Vishva Dixit | Vice President, Molecular Oncology Res |
| W. Robert Arathoon | Vice President, Corp Manufacturing Operations |
| Walter K. Moore | Vice President, Govt Affairs |
| William N. Anderson | Vice President, Sales & Marketing, Immunology |
| Herbert W. Boyer | Co Founder |
| Richard Axel | Co-founder |
| Avi Ashkenazi | Director |
| Dan Eaton | Director |
| Geoff Teeter | Director, Corp Communications |
| Hamilton Mixon | Director, Corp Security Services |
| Henry Lowman | Director, Engineering |
| Kathee Littrell | Director, Investor Relations |
| Lino Gonzalez | Senior Director |
| Lisa Tuomi | Associate Director, Investor Relations |
| Mark Sliwkowski | Director |
| Mary Stutts | Senior Director, Corp Communications |
| Mike Burchmore | Director, Prod Management |
| Nicholas Bruggen | Associate Director |
| Stuart Bunting | Director |
| Wai Wong | Director |
| Brad Failing | Area Manager, Sales, Managed Care |
| D. Searle | Manager, Marketing |
| Diane L. Parks | Senior Vice President & General Manager, Specialty Therapeutics & Managed Care |
| Diane Schrick | Prod Manager, Development |
| Sam Burst | Division Manager, Sales |
| Robert Andreatta | Controller |
| Amos Smith | Consultant |
| Bradley Wolk | Engr, Process Development |
| Chung Hsu | Engr, Process Development |
| Colin Watanabe | Programmer Analyst, Corp IT |
| Jonathan K.C. Knowles | Head, Global Research |
| Robert van Reis | Engr, Process Development |
| Charles A. Sanders | Director |
| Grant Heidrich | investor |
| Norman Fogelsong | Venture Investor |
| Susan Desmond | member |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Arthur D. Levinson | Chairman & Chief Executive Officer |
| Debra L. Reed | Board of Directors |
| Erich Hunziker | Board of Directors |
| William M. Burns | Board of Directors |
Arthur Levinson became chief executive officer of Genentech in July 1995. Levinson was appointed a member of the board of directors that same year and was named chairman of the board in 1999. Levinson joined the company in 1980 as a senior scientist, and he subsequently held the position of staff scientist and director of Cell Genetics at Genentech. He became vice president of Research Technology in 1989, vice president of Research in 1990, senior vice president of Research in 1992, and senior vice president of Research and Development in 1993. He has been a member of Genentech's executive committee since 1990. Prior to his employment with Genentech, Levinson was a postdoctoral fellow in the department of microbiology at the University of California, San Francisco. During his career, Levinson has served on the editorial boards of Molecular Biology and Medicine, Molecular and Cellular Biology, The Journal of Virology, and Virology. He also served on the boards of the Pharmaceutical Research and Manufacturers of America, the Biotechnology Industry Organization, and the California Healthcare Institute. Levinson has authored or co-authored more than 80 scientific articles and has been a named inventor on 11 United States patents, including inventions in the research of production of recombinant proteins. Levinson sits on the board of scientific consultants for the Memorial Sloan-Kettering Cancer Center and is a member of the advisory councils for the California Institute for Quantitative Biomedical Research (QB3), the Princeton University Department of Molecular Biology, and the Lewis-Sigler Institute for Integrative Genomics, also at Princeton. He also serves as a member of the executive council of the Technology Network. Levinson serves on the corporate boards of Apple Inc. and Google Inc. Levinson received the Irvington Institute's 1999 Corporate Leadership Award in Science and was honored the same year with the Corporate Leadership Award from the National Breast Cancer Coalition. He was inducted into the Biotech Hall of Fame at the 2003 Biotech Meeting of chief executive officers. BusinessWeek named Levinson one of the "Best Managers of the Year" in 2004 and 2005, and Institutional Investor named him "America's Best CEO" in the biotech category four years in a row (2004-2007). In 2006, Princeton University awarded Levinson the James Madison Medal for a distinguished career in scientific research and in biotechnology. Also in 2006, Barron's recognized Levinson as one of "The World's Most Respected CEOs," and the Best Practice Institute placed Levinson on their "25 Top CEOs" list. In 2008, Levinson was elected as a Fellow to the American Academy of Arts & Sciences. Levinson received his Bachelor of Science degree from the University of Washington, Seattle and earned a doctorate in biochemistry from Princeton University.
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Chairman & Chief Executive Officer | Current |
| Princeton University | Advisory Council, Lewis-Sigler Institute for Integrative Genomics | Current |
| Princeton University | Advisory Council, Department of Molecular Biology | Current |
| QB3 Co | Advisory Council | Current |
| Memorial Sloan-Kettering Cancer Center Inc. | Board of Scientific Consultants | Current |
| Memorial Sloan-Kettering Cancer Center Inc. | Member, Board of Scientific Consultants | Current |
| Google Inc. | Board of Directors | Current |
| Apple Inc. | Board of Directors | Current |
| Genentech, Inc. | Senior Vice President of R&D | Former |
| University of California, San Francisco | Postdoctoral Fellow | Former |
| California Healthcare Institute, Inc. | Board of Directors | Former |
| Pharmaceutical Research and Manufacturers of America | Board of Directors | Former |
| Biotechnology Industry Organization | Board of Directors | Former |
| Princeton University | Ph.D. in biochemistry | Former |
| University of Washington | Bachelor of Science degree in molecular biology | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | President, Product Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Executive Vice President and Chief Financial Officer | Current |
| Aquaya | Executive Vice President and Chief Financial Officer | Current |
| Intarcia Therapeutics, Inc. | Director | Current |
| Oppenheimer & Co. Inc. | research analyst | Former |
| Brown University | Bachelor of Arts in Economics and International Relations | Former |
| Genentech, Inc. | member | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Chief Medical Officer & Senior Vice President, Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Executive Vice President, Secretary and Chief Compliance Officer | Current |
| Wilson Sonsini Goodrich & Rosati | associate | Former |
| Iowa State University | Master of Science degree | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech Foundation | Executive Vice President, Commercial Operations | Current |
| Genentech, Inc. | Executive Vice President, Commercial | Current |
| Vernalis plc | Board of Directors | Current |
| Genentech Foundation | General Manager | Former |
| Pharmacia Corporation | Former | |
| Southampton University | Bachelor of Science Degree In Biological Sciences | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Executive Vice President, Product Operations | Current |
| Merck & Co. Inc. | Former | |
| The Ohio State University | doctorate in electrical engineering and computer science | Former |
| University of Cincinnati | Master of Science in electrical engineering | Former |
| National Chiao Tung University | Bachelor of Science | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Executive Vice President, Research | Current |
| Genentech Foundation | Executive Vice President, Research | Current |
| National Academy of Sciences | Board of Directors | Current |
| The Academy of Arts & Sciences | Board of Directors | Current |
| The Academy of Arts & Sciences | Member | Current |
| National Academy of Sciences | Member | Current |
| Genentech Foundation | Senior Vice President, Research | Former |
| California Institute of Technology | doctorate | Former |
| University of Wisconsin | Bachelor of Science | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Vice President, Res Drug Discovery | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Vice President, Regulatory, Quality & Compliance | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Immunology Res | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Process Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Fill, Finish Manufacturing | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Alliance Management & Pipeline Strategy Support | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Corp Engineering | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Biotherapeutics | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Decision Support & Commercial Innovation | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Biometrics & Business Operations, Medical Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President & General Manager, Oceanside Product Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Hematology & Oncology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, HR | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Vacaville Prod Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Commercial Quality, South San Francisco | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Regulatory Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Hematology & Oncology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Marketing Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President Finance, Treasury and Procurement | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, External Quality | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Compliance | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Business Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Development Sciences | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Manufacturing Collaborations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Small Molecule Drug Discovery | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Sales & Marketing, HER Family | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Oncology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Global Supply Chain | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Sales & Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Agensys, Inc. | President and CEO of Arca Discovery | Current |
| ARCA Discovery, Inc. | President and Chief Executive Officer | Current |
| Genentech, Inc. | Vice President, Marketing | Current |
| Crest Asset Management, Inc. | Partner | Current |
| Dendreon Corporation | Chairman | Current |
| Corus Pharma, Inc. | Board of Directors | Current |
| ARCA Discovery, Inc. | Board of Directors | Current |
| Anesiva Inc. | Board of Directors | Current |
| Agensys, Inc. | Board of Directors | Current |
| SRI International | Director | Current |
| Scios Inc. | Chief Executive Officer | Former |
| Scios, Inc. | CEO | Former |
| Scios Inc. | President | Former |
| Scios, Inc. | President | Former |
| Heartport, Inc. | Coo | Former |
| Johnson & Johnson | COO of Heartport | Former |
| American Heart Association, Inc. | chairman | Former |
| Dendreon Corporation | Board of Directors | Former |
| Northwestern University | M.B.A. | Former |
| Virginia Polytechnic Institute and State University | B.S. | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Quality, Global | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Sales & Marketing, Rituxan Immunology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Manufacturing, South San Francisco | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Corp IT | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical & Commercial Regulatory Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Prod Portfolio Management | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Molecular Oncology Res | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Corp Manufacturing Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Govt Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Sales & Marketing, Immunology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Co Founder | Current |
| University of California, San Francisco | Professor of Biochemistry | Current |
| Genentech, Inc. | Board of Directors | Current |
| Allergan, Inc. | Vice Chairman | Current |
| National Academy of Sciences | Board of Directors | Current |
| Allergan, Inc. | Board of Directors | Former |
| National Academy of Sciences | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Co-founder | Current |
| Columbia University | University Professor, Investigator | Former |
| University of California, San Francisco | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Corp Security Services | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Engineering | Current |
| The Johns Hopkins University | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Investor Relations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Associate Director, Investor Relations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Director, Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Prod Management | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Associate Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Area Manager, Sales, Managed Care | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Manager, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Vice President & General Manager, Specialty Therapeutics & Managed Care | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Prod Manager, Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Division Manager, Sales | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Controller | Current |
| Organization | Position | Status |
|---|---|---|
| Columbia University | Visiting Professor | Current |
| Cambridge University | Visiting Professor | Current |
| Red Abbey, LLC | Senior Advisor | Current |
| Genentech, Inc. | Consultant | Current |
| Auckland University | Visiting Professor | Current |
| Incyte Corporation | Consultant | Current |
| University of Pennsylvania | Professor | Current |
| Merck & Co. Inc. | Consultant | Current |
| University of Pennsylvania | Chairman | Current |
| Kosan Biosciences, Inc. | Board Advisor | Current |
| Dihedron Corp | Board Advisor | Current |
| Pharmacopeia Drug Discovery Inc. | Board Advisor | Current |
| Provid Pharmaceuticals, Inc. | Board of Directors | Current |
| Monell Chemical Senses Center | Member | Current |
| The Rockefeller University | Research Associate | Former |
| The Rockefeller University | Ph.D. | Former |
| Bucknell University | M.S. Degrees | Former |
| Bucknell University | B.S. | Former |
| The Rockefeller University | B.S. | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Engr, Process Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Engr, Process Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Programmer Analyst, Corp IT | Current |
| Organization | Position | Status |
|---|---|---|
| Roche Holding Ltd. | Managing Director, Global Pharmaceutical Research | Current |
| Genentech, Inc. | Head, Global Research | Current |
| Genentech, Inc. | Board of Directors | Current |
| Chugai Pharmaceutical Co., Ltd. | Board of Directors | Current |
| University of East Anglia | Honours Degree in Molecular Genetics | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Engr, Process Development | Current |
| Organization | Position | Status |
|---|---|---|
| The University of North Carolina | Trustee | Current |
| marketRx Inc. | Current | |
| Feinstein Kean Healthcare | Current | |
| Vertex Pharmaceuticals Incorporated | Chairman of the Board | Current |
| Liposcience, Inc. | Chairman of the Board | Current |
| Venrock Associates | Chairman of the Board of Directors | Current |
| Icagen, Inc. | Chairman | Current |
| Project Hope | Chairman | Former |
| Pharmacopeia Drug Discovery Inc. | Board of Directors | Current |
| Radius Ventures, LLC | Board of Directors | Current |
| Genentech, Inc. | Director | Current |
| Csis Inc | Board of Directors | Current |
| Cephalon, Inc. | Board of Directors | Current |
| Trimeris, Inc. | Director | Current |
| Icagen, Inc. | Board of Directors | Current |
| Drug Safety Alliance, Inc. | Board of Directors | Current |
| Kendle International Inc. | Director | Current |
| Scios, Inc. | Director | Current |
| Reata Pharmaceuticals, Inc | Board of Directors | Current |
| Epiphany Biosciences, Inc. | Board of Directors | Current |
| Staffmark | Board of Directors | Current |
| Personalized Medicine Coalition | Board of Directors | Current |
| Science & Technology Group | CEO | Former |
| Massachusetts Gen Hospital | General Director | Former |
| Massachusetts General Hospital | General Director | Former |
| Harvard Medical School | director of Massachusetts General Hospital | Former |
| Harvard Medical School | Professor of Medicine | Former |
| Meredith College | trustee | Former |
| Scios Inc. | Former | |
| New York Academy of Sciences | Chairman | Former |
| The Commonwealth Fund | Chairman | Former |
| Genaera Corporation | Board of Directors | Former |
| Vertex Pharmaceuticals Incorporated | Board of Directors | Current |
| Squibb Corporation | Board Member | Former |
| Squibb Corporation | Vice Chairman | Former |
| Massachusetts General Hospital | Director | Former |
| Biopure Corporation | Director | Former |
| The University of Texas Southwestern Medical School | M.D. | Former |
| The University of Texas | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Roche Holding Ltd. | CFO | Current |
| F. Hoffmann-La Roche Ltd. | CFO | Current |
| Chugai Pharmaceutical Co., Ltd. | Board of Directors | Current |
| Genentech, Inc. | Board of Directors | Current |
| Holcim Ltd. | Board of Directors | Current |
| Diethelm Keller Holding Ltd. | Chief Executive Officer | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Mayfield Fund | Partner Emeritus | Current |
| Prospect Venture Partners | Advisor | Current |
| DoveBid, Inc. | Director | Current |
| Cytokinetics, Inc. | Board of Directors | Current |
| Millennium Pharmaceuticals, Inc. | Board of Directors | Current |
| Genentech, Inc. | investor | Current |
| DoveBid, Inc. | investor | Current |
| SGI Inc. | investor | Current |
| Tularik, Inc. | investor | Current |
| Millennium Pharmaceuticals, Inc. | investor | Current |
| Amgen Inc. | investor | Current |
| Cytokinetics, Inc. | investor | Current |
| MIPS Technologies, Inc. | investor | Current |
| Immunex Corporation | investor | Current |
| Western Association of Venture Capitalists | President | Former |
| Aveo Pharmaceuticals, Inc. | Former | |
| Tularik, Inc. | Chairman of the Board | Former |
| Columbia University | MBA | Former |
| Stanford University | BA | Former |
| Organization | Position | Status |
|---|---|---|
| International Venture Partners, Inc. | General Partner | Current |
| Cortina Systems Corporation | Board of Directors | Current |
| Genentech, Inc. | Venture Investor | Current |
| Verisity, Ltd. | Venture Investor | Current |
| Aspect Software, Inc. | Investor | Current |
| 3Com Corporation | Venture Investor | Current |
| Cypress Semiconductor Corporation | Venture Investor | Current |
| Silicon Graphics, Inc. | Venture Investor | Current |
| Artisan Components, Inc. | Investor | Current |
| WebEx Communications, Inc. | Venture Investor | Current |
| MIPS Technologies, Inc. | Venture Investor | Current |
| LSI Corporation | Venture Investor | Current |
| Applied Biosystems Group | Venture Investor | Current |
| Dust Networks | Venture Investor | Current |
| Linear Technology Corp. | Venture Investor | Current |
| SupportSoft, Inc. | Venture Investor | Current |
| Concur Technologies, Inc. | Investor | Current |
| Compaq Computers | Investor | Current |
| Websense Inc. | Investor | Current |
| Lam Research Corporation | Investor | Current |
| Polycom, Inc. | Investor | Current |
| Motion Computing, Inc. | Investor | Current |
| @Road, Inc. | Venture Investor | Current |
| Amgen Inc. | Venture Investor | Current |
| Quantum Corporation | Venture Investor | Current |
| Digital River, Inc. | Venture Investor | Current |
| Institutional Venture Partners | General Partner | Former |
| Hewlett-Packard Company | computer programmer | Former |
| McKinsey & Company, Inc. | management consultant | Former |
| Stanford University | Board Member | Former |
| Harvard Law School | J.D | Former |
| Harvard Business School | M.B.A | Former |
| Stanford University | B.S. degree in Management Science & Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | member | Current |
| The University of California, San Francisco | Assistant Professor | Former |
| University of California, Berkeley | Master of Science degree in Epidemiology and Biostatistics | Former |
| University of Nevada | Bachelor of Science in Pre-Medicine and her Medical Degree | Former |
| University of California, San Francisco | adjunct associate professor of Epidemiology and Biostatistics | Former |
Executive News
-
Someone at Apple Should Pay
-
Wanted: A Few Disruptive Leaders
-
Experts: Apple Disclosure 'Falls Short'
-
Apple adapts to Jobs' absence
-
Report: Apple's Steve Jobs had liver transplant while on leave
-
Google Maintains Cool Facade as Antitrust Heat Builds
-
Google downplays antitrust concerns
-
U.S. Steps Up Probe of Google Book Deal
-
DOJ Probes Hiring at Tech Firms
-
Apple, Google, Microsoft, others may be under scrutiny for hiring practices
-
Reports: U.S. probes Silicon Valley tech giants' hiring
-
Apple, Google, Microsoft, others may be under scrutiny for hiring practices
-
Report: Antitrust probe of Apple, Google, Yahoo
-
New Warning on Hormone Replacement
-
Phase III Study Showed Patients Lived Longer Without Advanced Lung Cancer Progressing When Tarceva Was Added to Avastin as First-Line Maintenance Therapy
-
Phase III Study Showed Patients Lived Longer Without Advanced Lung Cancer Progressing When Tarceva Was Added to Avastin as First-Line Maintenance Therapy
-
Genentech Announces Full Results from First Phase III Study of Avastin in Early-Stage Colon Cancer
-
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival inAdvanced Breast Cancer
-
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival in Advanced Breast Cancer
-
Genentech, Biogen Idec seek new FDA approval for Rituxan
Industry Transcripts by Seeking Alpha
-
BMP Sunstone Corporation Q1 2009 Earnings Call Transcript
on Jun 30, 2009about BJGP
-
Matrixx Initiatives, Inc., F4Q09 (Qtr End 03/31/09) Earnings Call Transcript
on May 12, 2009about MTXX
-
King Pharmaceuticals Inc., Q1 2009 Earnings Call Transcript
on May 11, 2009about KG
-
Flamel Technologies SA Q1 2009 Earnings Call Transcript
on May 11, 2009about FLML
-
Sucampo Pharmaceuticals, Inc. Q1 2009 Earnings Call Transcript
on May 08, 2009about SCMP
Glass Door
IndustryTop Rated
- AstraZeneca's Seroquel Research Director Confessed to Sex-for-Studies Affairs 17 votes
- Forest Labs' Lexapro Flap Over JAMA Article Will Likely Be Examined by the Feds 11 votes
- Medarex Execs Got 10% Pay Raise Despite Delivering Nothing 11 votes
- Pfizer District Sales Manager Guilty of Altering Off-Label Celebrex Documents 10 votes
- Schering CEO Hassan Has $59 Million Buyout Agreement in Merck Merger 10 votes
